According to Apollo Endosurgery's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 7.54292. At the end of 2022 the company had a P/S ratio of 5.40.
Year | P/S ratio | Change |
---|---|---|
2022 | 5.40 | 2.11% |
2021 | 5.29 | 153.51% |
2020 | 2.09 | 77.31% |
2019 | 1.18 | -5.16% |
2018 | 1.24 | -17.37% |
2017 | 1.50 | -82.17% |
2016 | 8.43 | 79.18% |
2015 | 4.70 | -55.92% |
2014 | 10.7 | 49.44% |
2013 | 7.14 | -27.8% |
2012 | 9.89 | 28.87% |
2011 | 7.67 | 11.99% |
2010 | 6.85 | 92.4% |
2009 | 3.56 | -81.55% |
2008 | 19.3 | -93.12% |
2007 | 281 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Merit Medical MMSI | 3.56 | -52.81% | ๐บ๐ธ USA |
Inari Medical
NARI | 4.95 | -34.44% | ๐บ๐ธ USA |